Page last updated: 2024-11-02

pamidronate and Lupus Erythematosus, Systemic

pamidronate has been researched along with Lupus Erythematosus, Systemic in 1 studies

Lupus Erythematosus, Systemic: A chronic, relapsing, inflammatory, and often febrile multisystemic disorder of connective tissue, characterized principally by involvement of the skin, joints, kidneys, and serosal membranes. It is of unknown etiology, but is thought to represent a failure of the regulatory mechanisms of the autoimmune system. The disease is marked by a wide range of system dysfunctions, an elevated erythrocyte sedimentation rate, and the formation of LE cells in the blood or bone marrow.

Research Excerpts

ExcerptRelevanceReference
"Ectopic calcinosis rarely occurs in systemic lupus erythematosus (SLE) patients."2.39Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus. ( Ishikawa, H; Ito, O; Kasukawa, R; Kurokawa, M; Miyata, M; Nishimaki, T; Sekine, H; Watanabe, S, 1996)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Miyata, M1
Kurokawa, M1
Watanabe, S1
Ishikawa, H1
Sekine, H1
Ito, O1
Nishimaki, T1
Kasukawa, R1

Reviews

1 review available for pamidronate and Lupus Erythematosus, Systemic

ArticleYear
Periarticular ectopic calcinosis probably due to 1 alpha-OH-vitamin D3 therapy, and successful treatment with bisphosphonate compound in a patient with systemic lupus erythematosus.
    Fukushima journal of medical science, 1996, Volume: 42, Issue:1-2

    Topics: Adult; Calcinosis; Diphosphonates; Female; Finger Joint; Humans; Hydroxycholecalciferols; Lupus Eryt

1996